Platelet transfusion in brain haemorrhage

Completed

• Conditions: Intracerebraal hematoomCVABeroerteTrombocyten transfusieIntracerebral haemorrhageStrokePlatelet transfusionAnti-platelet therapy

• Registration Number: NL-OMON28517
• Lead Sponsor: AMC

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 190

Inclusion Criteria

1. Age > 18 years

2. Non-traumatic, primary, supratentorial ICH

Exclusion Criteria

1. Bleeding pattern on CT suggestive of AVM or aneurysm

2. Haematoma evacuation planned < 24 hrs

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Poor outcome defined as a modified Rankin Scale (mRS) score 4-6 after 3 months.

Secondary Outcome Measures

Name	Time	Method
- Haematoma growth on CT in the first 24 hours<br /><br>- Complications of platelet transfusion <br /><br>- Whether the CTA spot sign can predict primary outcome<br /><br>- Whether the CTA spot sign can predict haematoma enlargement on CT<br /><br>- Survival rate and level of physical disability at three months<br /><br>- Functional health at three months using the full ordinal scoring range of the mRS<br /><br>- Costs<br />